CA48226-1 - 0x0000000000006733

Males & Females of Non-Childbearing Potential

Jewel

* Stipend may pay up to reflected amount.
Start Date: 
July 8, 2025 - 5:30am
End Date: 
August 23, 2025 - 11:30am

Study Details

Study Number: CA48226
Group Number: 1
Study Requirement: Healthy Normal Male and Female
Stipend: up to $10,500.00

Study Criteria

Age: 19 - 55
BMI: 18.5 - 29.9
Weight Restriction: minimum weight 111 lbs

Study Information

Indication: This investigational medication is being developed to treat atrial fibrillation.
Route of Administration: Oral
Blood Draws: 50

Study Schedule

Schedule Type: Long Term
Study Length: 17 Night Stay & 1 Phone Call

Screening Dates:

Event Day Event Date
Thursday 6/26/2025
Friday 6/27/2025
Tuesday 7/1/2025
Wednesday 7/2/2025
Thursday 7/3/2025
Monday 7/7/2025

Doctor Exam Dates:

Event Day Event Date
Thursday 6/26/2025
Friday 6/27/2025
Tuesday 7/1/2025
Wednesday 7/2/2025
Thursday 7/3/2025
Monday 7/7/2025

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Tuesday 7/8/2025 5:30:00 AM 7/25/2025 8:30:00 AM 1 Lincoln
Phone participant Saturday 8/23/2025 11:30:00 AM 2 Lincoln